Radnor Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $897K | Hold |
5,725
| – | – | 0.13% | 172 |
|
|
2026
Q1 | $874K | Hold |
5,725
| – | – | 0.13% | 172 |
|
|
2025
Q4 | $789K | Hold |
5,725
| – | – | 0.12% | 177 |
|
|
2025
Q3 | $734K | Hold |
5,725
| – | – | 0.11% | 189 |
|
|
2025
Q2 | $693K | Buy |
5,725
+275
| +5% | +$31K | 0.11% | 195 |
|
|
2025
Q1 | $608K | Hold |
5,450
| – | – | 0.1% | 198 |
|
|
2024
Q4 | $530K | Sell |
5,450
-1,075
| -16% | -$115K | 0.09% | 217 |
|
|
2024
Q3 | $751K | Buy |
6,525
+600
| +10% | +$68.1K | 0.11% | 197 |
|
|
2024
Q2 | $631K | Hold |
5,925
| – | – | 0.19% | 103 |
|
|
2024
Q1 | $573K | Sell |
5,925
-300
| -5% | -$30.8K | 0.1% | 204 |
|
|
2023
Q4 | $629K | Sell |
6,225
-150
| -2% | -$14.5K | 0.12% | 187 |
|
|
2023
Q3 | $649K | Sell |
6,375
-300
| -4% | -$30.5K | 0.13% | 182 |
|
|
2023
Q2 | $674K | Buy |
+6,675
| New | +$668K | 0.29% | 75 |
|
|
2023
Q1 | – | Sell |
-6,825
| Closed | -$623K | – | 234 |
|
|
2022
Q4 | $623K | Sell |
6,825
-520
| -7% | -$43.8K | 0.15% | 147 |
|
|
2022
Q3 | $558K | Buy |
7,345
+300
| +4% | +$24.9K | 0.16% | 142 |
|
|
2022
Q2 | $596K | Hold |
7,045
| – | – | 0.16% | 146 |
|
|
2022
Q1 | $618K | Sell |
7,045
-850
| -11% | -$73.6K | 0.16% | 149 |
|
|
2021
Q4 | $691K | Sell |
7,895
-1,630
| -17% | -$135K | 0.17% | 140 |
|
|
2021
Q3 | $779K | Hold |
9,525
| – | – | 0.46% | 40 |
|
|
2021
Q2 | $869K | Hold |
9,525
| – | – | 0.29% | 83 |
|
|
2021
Q1 | $814K | Sell |
9,525
-650
| -6% | -$58.3K | 0.26% | 95 |
|
|
2020
Q4 | $961K | Buy |
10,175
+50
| +0.5% | +$4.37K | 0.27% | 83 |
|
|
2020
Q3 | $880K | Sell |
10,125
-200
| -2% | -$17.3K | 0.29% | 76 |
|
|
2020
Q2 | $907K | Hold |
10,325
| – | – | 0.33% | 69 |
|
|
2020
Q1 | $851K | Hold |
10,325
| – | – | 0.35% | 66 |
|
|
2019
Q4 | $978K | Hold |
10,325
| – | – | 0.3% | 75 |
|
|
2019
Q3 | $897K | Hold |
10,325
| – | – | 0.29% | 80 |
|
|
2019
Q2 | $943K | Sell |
10,325
-1,198
| -10% | -$101K | 0.31% | 76 |
|
|
2019
Q1 | $993K | Hold |
11,523
| – | – | 0.33% | 75 |
|
|
2018
Q4 | $886K | Hold |
11,523
| – | – | 0.32% | 76 |
|
|
2018
Q3 | $890K | Buy |
11,523
+56
| +0.5% | +$4.14K | 0.28% | 84 |
|
|
2018
Q2 | $776K | Hold |
11,467
| – | – | 0.29% | 85 |
|
|
2018
Q1 | $831K | Sell |
11,467
-781
| -6% | -$59.5K | 0.28% | 81 |
|
|
2017
Q4 | $921K | Buy |
12,248
+279
| +2% | +$21.1K | 0.29% | 80 |
|
|
2017
Q3 | $895K | Hold |
11,969
| – | – | 0.3% | 77 |
|
|
2017
Q2 | $895K | Hold |
11,969
| – | – | 0.3% | 77 |
|
|
2017
Q1 | $797K | Buy |
11,969
+139
| +1% | +$9.26K | 0.27% | 82 |
|
|
2016
Q4 | $772K | Buy |
+11,830
| New | +$767K | 0.26% | 84 |
|
Other funds holding NVS
Radnor Capital Management's NVS Position: Q2 2026 in Review
Radnor Capital Management held its Novartis (NVS) position steady in Q2 2026 at 5,725 shares worth $897K. The position accounts for 0.13% of the portfolio, ranked #172.
Radnor Capital Management first reported a position in NVS in Q4 2016 and has held it in 38 quarters since. The position peaked at $993K in Q1 2019. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Radnor Capital Management held 5,725 shares of Novartis worth $897K as of Q2 2026.
- Radnor Capital Management left its Novartis share count unchanged in Q2 2026.
- Novartis made up 0.13% of Radnor Capital Management's portfolio in Q2 2026, its #172 holding.
- Radnor Capital Management first reported a position in Novartis in Q4 2016 and has held it in 38 quarters since.
- Radnor Capital Management's Novartis position peaked at $993K in Q1 2019.
- 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Radnor Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.